Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biogen
Pharma
Biogen CEO's 2023 pay shrank by 87%
After receiving a sign-on package worth $30.5 million, Biogen CEO Chris Viehbacher's 2023 pay shrank to just $4.1 million thanks to a prior agreement.
Angus Liu
Apr 16, 2024 1:00pm
Eisai, Carvykti, Ozempic biosimilar—Fierce Pharma Asia
Apr 5, 2024 8:25am
Eisai, Biogen's subQ Leqembi delayed amid FDA's data request
Apr 1, 2024 10:45am
The top 10 drugs losing US exclusivity in 2024
Mar 11, 2024 3:00am
Amid launch hurdles, Eisai updates Leqembi's sales forecast
Mar 7, 2024 11:29am
Eisai's Leqembi launch tripped up on a host of challenges
Feb 27, 2024 9:20am